| Literature DB >> 34991900 |
Elisa Fontenelle de Oliveira1, Camila Penedo2, Solange Oliveira Rodrigues Valle3, Fábio Chigres Kuschnir4.
Abstract
BACKGROUND: The prevalence of atopic eczema is unknown in many countries. The International Study of Asthma and Allergies in Childhood (ISAAC) is an epidemiological landmark in the study of allergic diseases.Entities:
Keywords: Atopic eczema; Epidemiology; Pediatrics; Validation study
Mesh:
Year: 2022 PMID: 34991900 PMCID: PMC9073231 DOI: 10.1016/j.abd.2021.03.010
Source DB: PubMed Journal: An Bras Dermatol ISSN: 0365-0596 Impact factor: 2.113
Figure 1ISAAC Written Atopic Eczema questionnaire (WAEQ) for children between 6 and 7 years of age.
Reproducibility of atopic eczema indicators of the ISAAC written atopic eczema questionnaire (WAEQ) for children aged 6–7 years applied through telephone interviews with their caregivers (n = 84) Rio de Janeiro, 2020.
| Indicator | Agreement n (%) | Kappa Coefficient (κ) | 95% CI | p-value |
|---|---|---|---|---|
| Recurrent pruritic lesions | 76 (90.5) | 0.82 | 0.71–0.93 | <0.001 |
| Lesions in the last 12 months | 74 (87.9) | 0.78 | 0.67–0.90 | <0.001 |
| Lesions in typical locations | 76 (90.5) | 0.81 | 0.69–0.93 | <0.001 |
| Age at onset | 70 (83.4) | 0.71 | 0.58–0.83 | <0.001 |
| Complete improvement in the last 12 months | 68 (81.0) | 0.66 | 0.52–0.79 | <0.001 |
| Sleep disturbance in the last 12 months | 72 (85.7) | 0.74 | 0.62–0.87 | <0.001 |
| Presence of eczema | 77 (91.0) | 0.70 | 0.52–0.96 | <0.001 |
95% CI, 95% Confidence Interval.
Total number and percentage of concordant responses between the 2 telephone interviews.
Validation of Written Atopic Eczema Questionnaire (WAEQ) eczema indicators for children aged 6–7 years obtained through telephone interviews with the guardians compared to the clinical diagnosis of atopic eczema (n = 88). Rio de Janeiro, 2020.
| Indicator | Sensitivity (%) | Specificity (%) | Accuracy (%) |
|---|---|---|---|
| Recurrent pruritic lesions | 93.8 | 80.4 | 85.0 |
| Lesions in the last 12 months | 87.5 | 91.1 | 89.0 |
| Lesions in typical locations | 87.5 | 96.4 | 93.0 |
| Age at onset | 87.5 | 91.1 | 89.0 |
| Complete improvement in the last 12 months | 34.4 | 91.1 | 70.0 |
| Sleep disturbance in the last 12 months | 87.5 | 91.1 | 89.0 |
| Presence of eczema | 40.6 | 98.2 | 77.0 |
Agreement between the in-person responses to the Written Atopic Eczema Questionnaire (WAEQ) provided by caregivers of children aged 6–7 years and the responses obtained at the 1st telephone interview (n = 84). Rio de Janeiro, 2020.
| Indicator | Agreement n(%) | Kappa Coefficient (κ) | 95% CI | p-value |
|---|---|---|---|---|
| Recurrent pruritic lesions | 78 (92.9) | 0.85 | 0.73–0.96 | <0.001 |
| Lesions in the last 12 months | 75 (89.3) | 0.81 | 0.69–0.92 | <0.001 |
| Lesions in typical locations | 77 (91.7) | 0.83 | 0.70–0.95 | <0.001 |
| Age at onset | 73 (86.9) | 0.76 | 0.63–0.88 | <0.001 |
| Complete improvement in the last 12 months | 71 (84.5) | 0.71 | 0.57–0.84 | <0.001 |
| Sleep disturbance in the last 12 months | 72 (85.7) | 0.73 | 0.59–0.86 | <0.001 |
| Presence of eczema | 79 (94.0) | 0.76 | 0.56–0.96 | <0.001 |
95% CI, 95% Confidence Interval.
Total number and percentage of concordant responses between the 1st telephone interview and the in-person interview.